Drug Type Recombinant vector vaccine, Shared antigen vaccine, Therapeutic vaccine |
Synonyms VM 206, VM-206, VM-206RY + [2] |
Target |
Action modulators |
Mechanism HER2 modulators(Receptor tyrosine-protein kinase erbB-2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 1 | United States | 01 Mar 2011 | |
Breast Cancer | Phase 1 | South Korea | 01 Mar 2011 |